2024-09-02 - Analysis Report
## CVS Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services.

**Performance Analysis:**

1. **Performance vs. S&P 500 (VOO):**  CVS has significantly underperformed the S&P 500, with a cumulative return of -17.37% compared to the S&P 500's 89.66%. This represents a gap of -107.03%, indicating that CVS has been trailing the market considerably. 

2. **Recent Price Action:**
    * **Closing Price:** 57.24
    * **5-day Moving Average:** 57.52
    * **20-day Moving Average:** 57.56
    * **60-day Moving Average:** 58.95

    The price is currently trading below all three moving averages, suggesting a short-term downtrend. However, the proximity to the moving averages indicates potential for a reversal.

3. **Technical Indicators:**
    * **RSI (Relative Strength Index):** 59.78
    * **PPO (Percentage Price Oscillator):** -0.05
    * **Delta_Previous_Relative_Divergence:** -11.1 (indicates a short-term downtrend)
    * **Expected Return:** 12.6% (Represents the maximum expected 5-year return on current investment)

    The RSI is in the neutral zone, indicating neither strong bullish nor bearish momentum. The PPO is negative, signifying a downtrend. The negative Delta_Previous_Relative_Divergence confirms a short-term downtrend. However, the Expected Return remains positive, suggesting long-term potential.

4. **Recent Earnings:**
    | Date | EPS | Estimated EPS |
    |---|---|---|
    | 2024-08-07 | 1.83 | 1.73 |
    | 2024-05-01 | 1.31 | 1.7 |
    | 2024-02-07 | 2.12 | 2.01 |
    | 2023-11-01 | 2.21 | 2.13 |
    | 2023-08-02 | 2.21 | 2.12 |

    The most recent earnings report (2024-08-07) shows an EPS of 1.83, exceeding the estimated EPS of 1.73. This indicates a positive earnings surprise, potentially boosting investor sentiment. However, the trend of EPS over the past few quarters shows a declining pattern, suggesting potential challenges in future earnings growth.

**Overall Analysis:**

CVS is currently facing significant challenges, reflected in its underperformance compared to the market and recent price action. The technical indicators suggest a short-term downtrend, while the recent earnings performance has shown mixed signals. While the company managed to beat earnings estimates in the most recent quarter, the overall trend in EPS remains concerning. Investors should monitor the company's future earnings announcements, business strategies, and market sentiment to make informed investment decisions. Despite the current challenges, the positive Expected Return suggests a potential for long-term growth, particularly if CVS successfully addresses the concerns regarding earnings growth and improves its performance relative to the market. 
